Acadia Healthcare Company Inc

In a Stage 2 advancing regime within a secular downtrend, ACHC exhibits a higher-highs/higher-lows continuation pattern with rising EMAs. Price is extended above the dynamic support band into extreme overbought territory, suggesting short-term exhaustion. Medium-term bias remains bullish, but timing warrants patience—defer entry and stake out pullbacks toward the rising EMA support zone for a structurally favorable set-up.

• ↑Plans to add 400–600 beds in 2026 after adding 2,500+ beds
• ↑Q1 2026 revenue of $828.8M (+7.6% YoY) and adjusted EBITDA of $144.2M
• ↓6.5% revenue decline in specialty facilities in Pennsylvania